Guide for Authors
Editorial Policy and Types of Contribution
Cancer Treatment Reviews is an international review journal that will keep both the clinician and researcher abreast of modern concepts and developments in cancer treatment research through the publication of state of the art, authoritative reviews; evidence-based reviews (using a priori defined selection process to identify key articles from the literature and reviewing them in the form of a structured abstract, evidence summary and commentary); and systematic reviews. Each issue provides topical reviews under the following regular sections:
• comments on controversy
• tumour reviews
• anti-tumour treatments
• new drugs
• complications of treatment
• general and supportive care
• laboratory/clinic interface
Authors will be asked to assign their contribution to one of the above areas.
The journal has a limit of 5000 words and 6 figures or tables for each review article. A maximum of 100 references is recommended although exceptions can be made subject to the approval of the Editors in Chief.
Prior to Submission of an ArticleSubmission of an article assumes that:
• The work has not been published previously, except in the form of an abstract, as part of a published lecture or academic thesis.
• That, if accepted, it will not be published elsewhere in the same form, in English or in any other language without the written consent of the copyright holder, Elsevier.
• All listed authors concur with the submission and have approved the final manuscript.
• Articles are written in good English. Authors whose native language is not English are strongly advised to have their manuscript checked by an English-speaking colleague who understands the material.
Randomised controlled trialsEthics
All randomised controlled trials submitted for publication in Cancer Treatment Reviews should include a completed Consolidated Standards of Reporting Trials (CONSORT) flow chart. Please refer to the CONSORT statement website at http://www.consort-statement.org for more information. Cancer Treatment Reviews has adopted the proposal from the International Committee of Medical Journal Editors (ICMJE) which require, as a condition of consideration for publication of clinical trials, registration in a public trials registry. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article. For this purpose, a clinical trial is defined as any research project that prospectively assigns human subjects to intervention or comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (e.g. phase I trials) would be exempt. Further information can be found at http://www.icmje.org.
Work on human beings that is submitted to Cancer Treatment Reviews should comply with the principles laid down in the Declaration of Helsinki; Recommendations guiding physicians in biomedical research involving human subjects. Adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964, amended by the 29th World Medical Assembly, Tokyo, Japan, October 1975, the 35th World Medical Assembly, Venice, Italy, October 1983, and the 41st World Medical Assembly, Hong Kong, September 1989. The manuscript should contain a statement that the work has been approved by the appropriate ethical committees related to the institution(s) in which it was performed and that subjects gave informed consent to the work. Studies involving experiments with animals must state that their care was in accordance with institution guidelines. Patients' and volunteers' names, initials, and hospital numbers should not be used.
Conflict of interestRole of the funding source All sources of funding should be declared as an acknowledgement at the end of the text. Authors should declare the role of study sponsors, if any, in the study design, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, the authors should so state.
At the end of the text, under a subheading "Conflict of interest statement" all authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
All contributors who do not meet the criteria for authorship as defined above should be listed in an acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support. Authors should disclose whether they had any writing assistance and identify the entity that paid for this assistance.
Upon acceptance of an article, authors will be asked to sign a "Journal Publishing Agreement"(for more information on this and copyright see http://authors.elsevier.com). Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail (or letter) will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form.
If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases : contact Elsevier's Rights Department, Philadelphia, PA, USA: Tel. (+1) 215 238 7869; Fax (+1) 215 238 2239; e-mail firstname.lastname@example.org. Requests may also be completed online via the Elsevier homepage (http://www.elsevier.com/locate/permissions).
Submission to Cancer Treatment Reviews proceeds totally online. You will be guided stepwise through the creation of and uploading of various files at http://ees.elsevier.com/ctr. The system automatically converts source files to a single Adobe Acrobat PDF version of the article, which is used in the peer-review process. Please note that even though manuscript source files are converted to PDF at submission for the review process, these source files are needed for further processing after acceptance. All correspondence, including notification of the Editor's decision and requests for revision, takes place by email, removing the need for a hard-copy paper trail. We accept text files in most standard word-processing formats but Microsoft Word, Word Perfect and LaTeX are preferred. Graphics should be high-resolution and the preferred formats are TIFF, EPS or PDF.
Please follow the instructions below for guidance on the style of the journal. Most formatting codes are removed or replaced when your article is prepared for publication so there is no need for you to use excessive layout styling. However, please do not use options such as automatic word breaking, justified layout, double columns or automatic paragraph numbering. Do use bold face, italic, subscripts, superscripts, etc., as appropriate. Please ensure that your manuscript is paginated, as this will help both editor and reviewers to process it promptly. An author responsible for corresponding with the Editor and Elsevier will need to be assigned.
Covering letterPreparation of the Manuscript - Specific
The online submission system requires a covering letter to be submitted with the manuscript. This should include the following information:
• Confirmation of the fact that the article is not under consideration for publication elsewhere.
• Confirmation of whether any parts i.e. figures, of the article have been sent by mail.
• Each author should have participated sufficiently in any submission to take public responsibility for its content. Please provide full contact details for each author.
• Publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out.
Sections of the ArticleSecond title page The second page should only bear the title (without information about the authors) for blind peer review.
First Title Page
Please create a title page for your article. The title should be clear, informative and not too long. In addition, please provide an abbreviated title of no more than seven words which will be used as a header. This page should bear names, full postal addresses, telephone and fax and email addresses of all author(s). The contact details of the corresponding author should be highlighted.
The abstract should concisely describe the content of the article. It should be no longer than 250 words. Abbreviations and references should be avoided in the abstract. An abstract is often presented separately from the article, so it must be able to stand alone.
Please list no more than 10.
Illustrations A detailed guide on electronic artwork is available at http://cdn.elsevier.com/assets/pdf_file/0010/109963/Artwork.pdf. Authors can submit artwork by post even if they submit the rest of their article using the online submission system. If so, they should draw the Editor's attention to this in the covering letter (see below for more details). Similar images should be consistent in size. Images should be tightly cropped. Figures may be reduced in size for publication. Mark the appropriate position of a figure in the article. Number illustrations consecutively in the order in which they are referred to in the text, and provide a caption for each figure. Colour illustrations cannot be accepted unless the author agrees to pay the additional production costs involved. Please note: Because of technical complications which can arise by converting colour figures to greyscale, please submit both black and white prints corresponding to all colour illustrations. Colour artwork will be published online.Electronic submission of artwork
• Files must be in the correct format: preferably TIFF, EPS or MS Office.Tables
• Images should be captured at the following minimum resolutions: halftones and colour (all colour must be RGB) 300 dpi; combination halftones 500 dpi; line art 1000-1200 dpi.
• Annotations to the figure, such as arrows and labels should be embedded in the electronic file.
• File names should be self-explanatory with file extension included, e.g. use filename "fig1.tif" for Figure 1 in TIFF format.
• All illustrations to be provided as separate files.
Number tables consecutively in arabic in accordance with their appearance in the text. If no grid is being used, use tabs to align columns instead of spaces. Each table should have a brief and self-explanatory title. Standard abbreviations of units of measurements should be added between parentheses. Place footnotes to tables below the table body and indicate them with superscript lowercase letters. Be sparing with the use of tables and ensure that the data presented in tables does not duplicate results described elsewhere in the article.
Equipment and DrugsUnits and Abbreviations
When quoting specific equipment or drugs, authors must state in parentheses the name and address of the manufacturer. Generic names should be used wherever possible since trade names vary from country to country.
Measurements of length, height, weight and volume should be given in metric units (metre, kilogram, litre) or their decimal multiples in terms of the International System of Units http://www.bipm.fr/en/si/. Temperatures should be given in degrees Celsius and blood pressure in mmHg. Define abbreviations that are not standard in the field at their first occurrence in the article, in the abstract but also in the main text after it. Ensure consistency of abbreviations throughout the text.
Supplementary data (including multimedia and video)References
The journal accepts electronic supplementary material to support and enhance your scientific research. Supplementary files allow the author to submit supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips and more, which will be published online alongside the electronic version of your article. In order to ensure that your submitted material is directly usable, please ensure that data is provided in one of the recommended file formats (for detailed guidance on formats for supplementary files see http://cdn.elsevier.com/assets/pdf_file/0010/109963/Artwork.pdf).
Responsibility for the accuracy of bibliographic citations lies entirely with the authors. They should be numbered consecutively as they appear in the text. All references in the reference list must be cited in the text (and vice versa). Any references cited in the abstract must be given in full. Indicate references by superscript numbers in the text. The actual authors can be referred to, but the reference number(s) must always be given. Unpublished results and personal communications should not be included in the reference list, but should be cited in the text only (e.g. Smith et al., unpublished results). Material conveyed by personal communication should be used only if permission for its publication and verification of the wording have been obtained. Citation of a reference as 'in press' implies that the item has been accepted for publication, please include the journal/book name and proposed year of publication in both the text and reference list. Citing and listing web references: as a minimum, the full url should be given. Any further information if known (author names, dates, reference to a source publication, etc.) should also be given. Web references can be listed separately (e.g. after the reference list) under a different heading if desired, or can be included in the reference list. In the reference list, number the references, in parentheses, in the order in which they appear in the text, and provide surname and initial of all authors. For references with more than six authors insert 'et al.' after the third name. Style and punctuation are shown in the following examples:
Please include the complete title of the article, journal name, volume and supplement number if appropriate, page range and year of publication. Chemical Abstracts should be consulted for abbreviations of journal serial titles.
1. Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. J Sci Commun 2000;163:51-9.
Please include the names of the authors, chapter title, editors (where appropriate), book title, edition, volume, page range, and location and name of publisher. For references to complete books please cite all the relevant information as stated above. 2. Strunk Jr W, White EB. The elements of style. 3rd ed. New York: Macmillan; 1979.
Chapter in a book:Funding Body Agreements and Policies
3. Mettam GR, Adams LB. How to prepare an electronic version of your article. In: Jones BS, Smith RZ, editors. Introduction to the electronic age New York: E-Publishing Inc; 1999, p. 281-304.
Elsevier has established agreements and developed policies to allow authors who publish in Elsevier journals to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please visit http://www.elsevier.com/fundingbodies.
One set of page proofs in PDF format will be sent by e-mail to the corresponding author (if we do not have an e-mail address then paper proofs will be sent by post). Elsevier now sends PDF proofs which can be annotated; for this you will need to download Adobe Reader version 7 available free from http://www.adobe.com/products/acrobat/readstep2.html. Instructions on how to annotate PDF files will accompany the proofs. The exact system requirements are given at the Adobe site: http://www.adobe.com/products/acrobat/acrrsystemreqs.html#70win. If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. We will do everything possible to get your article published quickly and accurately. Therefore, it is important to ensure that all of your corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed with the publication of your article if no response is received.
The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail or, alternatively, 25 free paper offprints. The PDF file is a watermarked version of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use. Additional paper offprints can be ordered by the authors. An order form with prices will be sent to the corresponding author.
Open AccessThis journal offers authors two choices to publish their research;
1. Open Access
• Articles are freely available to both subscribers and the wider public with permitted reuse
• An Open Access publication fee is payable by authors or their research funder
2. SubscriptionAll articles published Open Access will be immediately and permanently free for everyone to read and download. Permitted reuse is defined by your choice of one of the following Creative Commons user licenses:
• Articles are made available to subscribers as well as developing countries and patient groups through our access programs (http://www.elsevier.com/access)
• No Open Access publication fee
Creative Commons Attribution-Non Commercial-ShareAlike (CC BY-NC-SA): for non-commercial purposes, lets others distribute and copy the article, to create extracts, abstracts and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text and data mine the article, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, do not modify the article in such a way as to damage the author's honor or reputation, and license their new adaptations or creations under identical terms (CC BY NC SA).Creative Commons Attribution-NonCommercial-NoDerivs (CC-BY-NC-ND): for non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.
Creative Commons Attribution (CC-BY): available only for authors funded by organizations with which Elsevier has established an agreement. For a full list please see http://www.elsevier.com/fundingbodiesElsevier has established agreements with funding bodies. This ensures authors can comply with funding body Open Access requirements, including specific user licenses, such as CC-BY. Some authors may also be reimbursed for associated publication fees. http://www.elsevier.com/fundingbodies
To provide Open Access, this journal has a publication fee which needs to be met by the authors or their research funders for each article published Open Access. Your publication choice will have no effect on the peer review process or acceptance of submitted articles. The Open Access publication fee for this journal is 2500 USD, excluding taxes.Learn more about Elsevier's pricing policy http://www.elsevier.com/openaccesspricing